| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T9 |
0-174 |
Sentence |
denotes |
In recent decades, several new diseases have emerged in different geographical areas, with pathogens including Ebola virus, Zika virus, Nipah virus, and coronaviruses (CoVs). |
| T10 |
175-462 |
Sentence |
denotes |
Recently, a new type of viral infection emerged in Wuhan City, China, and initial genomic sequencing data of this virus do not match with previously sequenced CoVs, suggesting a novel CoV strain (2019-nCoV), which has now been termed severe acute respiratory syndrome CoV-2 (SARS-CoV-2). |
| T11 |
463-669 |
Sentence |
denotes |
Although coronavirus disease 2019 (COVID-19) is suspected to originate from an animal host (zoonotic origin) followed by human-to-human transmission, the possibility of other routes should not be ruled out. |
| T12 |
670-888 |
Sentence |
denotes |
Compared to diseases caused by previously known human CoVs, COVID-19 shows less severe pathogenesis but higher transmission competence, as is evident from the continuously increasing number of confirmed cases globally. |
| T13 |
889-1109 |
Sentence |
denotes |
Compared to other emerging viruses, such as Ebola virus, avian H7N9, SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 has shown relatively low pathogenicity and moderate transmissibility. |
| T14 |
1110-1217 |
Sentence |
denotes |
Codon usage studies suggest that this novel virus has been transferred from an animal source, such as bats. |
| T15 |
1218-1351 |
Sentence |
denotes |
Early diagnosis by real-time PCR and next-generation sequencing has facilitated the identification of the pathogen at an early stage. |
| T16 |
1352-1606 |
Sentence |
denotes |
Since no antiviral drug or vaccine exists to treat or prevent SARS-CoV-2, potential therapeutic strategies that are currently being evaluated predominantly stem from previous experience with treating SARS-CoV, MERS-CoV, and other emerging viral diseases. |
| T17 |
1607-1832 |
Sentence |
denotes |
In this review, we address epidemiological, diagnostic, clinical, and therapeutic aspects, including perspectives of vaccines and preventive measures that have already been globally recommended to counter this pandemic virus. |
